|
1
|
Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.
|
J Clin Invest
|
2003
|
2.66
|
|
2
|
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
|
Mol Cell Proteomics
|
2010
|
1.16
|
|
3
|
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.
|
Tumour Biol
|
2010
|
1.16
|
|
4
|
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
|
Gut
|
2011
|
1.15
|
|
5
|
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
|
J Proteomics
|
2010
|
1.04
|
|
6
|
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
|
Clin Biochem
|
2012
|
1.03
|
|
7
|
Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
|
Cell Oncol (Dordr)
|
2012
|
1.02
|
|
8
|
Molecular tests for colorectal cancer screening.
|
Clin Colorectal Cancer
|
2011
|
1.01
|
|
9
|
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
|
Gut
|
2011
|
0.96
|
|
10
|
Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum.
|
Virchows Arch
|
2008
|
0.90
|
|
11
|
The adenoma hunt in colorectal cancer screening: defining the target.
|
J Pathol
|
2011
|
0.88
|
|
12
|
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
|
Ann Surg
|
2016
|
0.87
|
|
13
|
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
|
Cell Oncol (Dordr)
|
2012
|
0.86
|
|
14
|
Carcinoma origin dictates differential skewing of monocyte function.
|
Oncoimmunology
|
2012
|
0.82
|
|
15
|
Lumican and versican are associated with good outcome in stage II and III colon cancer.
|
Ann Surg Oncol
|
2012
|
0.79
|
|
16
|
Control of lymphocyte infiltration of lung tumors in mice by host's genes: mapping of four Lynf (lymphocyte infiltration) loci.
|
Cancer Immunol Immunother
|
2007
|
0.79
|
|
17
|
Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats.
|
PLoS One
|
2011
|
0.79
|
|
18
|
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
|
Cell Oncol (Dordr)
|
2013
|
0.79
|
|
19
|
Paving the road towards non-invasive molecular imaging.
|
Cell Oncol
|
2006
|
0.75
|